Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-12-000314
Filing Date
2012-02-14
Accepted
2012-02-14 15:45:26
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT adamis_10q-123111.htm 10-Q 426069
2 THIRD AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT ex-10_1.htm EX-10.1 17955
3 302 CERTIFICATION OF THE CEO ex-31_1.htm EX-31.1 17870
4 302 CERTIFICATION OF THE CFO ex-31_2.htm EX-31.2 18695
5 906 CERTIFICATION OF THE CEO ex-32_1.htm EX-32.1 8107
6 906 CERTIFICATION OF THE CFO ex-32_2.htm EX-32.2 8378
  Complete submission text file 0001387131-12-000314.txt   1342496

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT admp-20111231.xml EX-101.INS 74487
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20111231.xsd EX-101.SCH 11616
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20111231_cal.xml EX-101.CAL 18917
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20111231_def.xml EX-101.DEF 5799
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20111231_lab.xml EX-101.LAB 93547
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20111231_pre.xml EX-101.PRE 58574
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 12609101
SIC: 2834 Pharmaceutical Preparations